Total Payments
$1,055
2024 Payments
$726.47
Companies
18
Transactions
60
Medicare Patients
490
Medicare Billing
$25,215
Payment Breakdown by Category
Food & Beverage$1,055 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,055 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $190.64 | 11 | $0 (2024) |
| Novo Nordisk Inc | $181.16 | 12 | $0 (2024) |
| Lilly USA, LLC | $180.12 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $107.16 | 5 | $0 (2024) |
| Amgen Inc. | $45.05 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $44.73 | 3 | $0 (2024) |
| Radius Health, Inc. | $42.64 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $42.55 | 2 | $0 (2024) |
| ABBVIE INC. | $36.44 | 2 | $0 (2024) |
| PFIZER INC. | $35.42 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $726.47 | 42 | Novo Nordisk Inc ($147.75) |
| 2023 | $328.22 | 18 | Lilly USA, LLC ($79.70) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Bone Health | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: VACCINES | ||||||
| 08/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VACCINES | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Central Nervous System | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Gastroenterology | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 490 | 543 | $35,965 | $25,215 |
Total Patients
490
Total Services
543
Medicare Billing
$25,215
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 237 | $20,692 | $11,809 | 57.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 54 | 60 | $8,558 | $8,387 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 35 | $4,303 | $2,867 | 66.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 20 | 21 | $675.15 | $449.82 | 66.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 49 | 52 | $445.64 | $436.80 | 98.0% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 11 | 11 | $385.99 | $378.29 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 46 | 49 | $380.73 | $372.89 | 97.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 29 | 29 | $306.24 | $300.15 | 98.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 36 | 37 | $117.29 | $115.07 | 98.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 12 | $101.52 | $99.48 | 98.0% |
About Maria Rivarola
Maria Rivarola is a Family healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1467905117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Rivarola has received a total of $1,055 in payments from pharmaceutical and medical device companies, with $726.47 received in 2024. These payments were reported across 60 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,055).
As a Medicare-enrolled provider, Rivarola has provided services to 490 Medicare beneficiaries, totaling 543 services with total Medicare billing of $25,215. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Asheville, NC
- Active Since 07/29/2016
- Last Updated 07/29/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1467905117
Products in Payments
- MOUNJARO (Drug) $145.73
- SHINGRIX (Biological) $117.03
- XIFAXAN (Drug) $107.16
- Wegovy (Drug) $92.23
- TRELEGY ELLIPTA (Drug) $55.28
- Ozempic (Drug) $51.45
- Tymlos (Drug) $42.64
- VOQUEZNA (Drug) $42.55
- Rybelsus (Drug) $37.48
- JARDIANCE (Drug) $34.39
- XARELTO (Drug) $34.24
- BREZTRI (Drug) $31.27
- Otezla (Drug) $30.99
- QULIPTA (Drug) $22.56
- PAXLOVID (Drug) $21.92
- Austedo XR (Drug) $19.72
- AREXVY (Drug) $18.33
- FLOWTRIEVER CATHETER, S (Device) $17.69
- Cologuard Collection Kit (Device) $17.47
- BELSOMRA (Drug) $15.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Asheville
Mr. Frank Russo, Fnp, FNP
Family — Payments: $5,583
Family $5,583
Leah Zambouros, Np-C, NP-C
Family — Payments: $5,516
Family $5,516
Rebecca Lockwood, Arnp, ARNP
Family — Payments: $5,073
Family $5,073
Donna Gibson, Msned, Rn, Fnp-C, MSNED, RN, FNP-C
Family — Payments: $3,484
Family $3,484
Mrs. Nicole Clinchard, Fnp, FNP
Family — Payments: $2,247
Family $2,247
Jennifer Lepkowski, Fnp-C, FNP-C
Family — Payments: $2,116
Family $2,116